Insider Transactions in Q1 2023 at Syndax Pharmaceuticals Inc (SNDX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 13
2023
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct |
52,854
-74.77%
|
$1,162,788
$22.53 P/Share
|
|
Mar 13
2023
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct |
52,854
+42.78%
|
$317,124
$6.38 P/Share
|
|
Feb 15
2023
|
Peter Ordentlich Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-100.0%
|
$625,000
$25.84 P/Share
|
|
Feb 15
2023
|
Peter Ordentlich Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$150,000
$6.79 P/Share
|
|
Feb 06
2023
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct |
52,854
-74.77%
|
$1,374,204
$26.83 P/Share
|
|
Feb 06
2023
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct |
52,854
+42.78%
|
$317,124
$6.38 P/Share
|
|
Feb 06
2023
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,959
-25.23%
|
$160,893
$27.64 P/Share
|
|
Feb 06
2023
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,959
+20.15%
|
$35,754
$6.38 P/Share
|
|
Feb 02
2023
|
William Meury |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+25.0%
|
-
|
|
Feb 02
2023
|
Martin H. Huber Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+33.33%
|
-
|
|
Feb 02
2023
|
Dennis Podlesak |
BUY
Grant, award, or other acquisition
|
Direct |
32,000
+22.9%
|
-
|
|
Feb 02
2023
|
Jennifer Jarrett |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+25.0%
|
-
|
|
Feb 02
2023
|
Keith Katkin |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+25.0%
|
-
|
|
Feb 02
2023
|
Pierre Legault |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+25.0%
|
-
|
|
Feb 01
2023
|
Peter Ordentlich Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
69
-100.0%
|
$1,932
$28.43 P/Share
|
|
Jan 31
2023
|
Peter Ordentlich Chief Scientific Officer |
BUY
Other acquisition or disposition
|
Direct |
69
+50.0%
|
$1,173
$17.32 P/Share
|
|
Jan 13
2023
|
Pierre Legault |
SELL
Open market or private sale
|
Direct |
15,000
-18.66%
|
$405,000
$27.0 P/Share
|
|
Jan 13
2023
|
Pierre Legault |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+15.57%
|
$195,000
$13.58 P/Share
|
|
Jan 12
2023
|
Pierre Legault |
SELL
Open market or private sale
|
Direct |
24,000
-42.86%
|
$624,000
$26.74 P/Share
|
|
Jan 12
2023
|
Pierre Legault |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+30.0%
|
$216,000
$9.47 P/Share
|